U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Drugs
  3. Drug Safety and Availability
  4. Postmarket Drug Safety Information for Patients and Providers
  5. Fentanyl Transdermal System (marketed as Duragesic) Information
  1. Postmarket Drug Safety Information for Patients and Providers

Fentanyl Transdermal System (marketed as Duragesic) Information

The fentanyl transdermal system (patch) is used for the management of persistent, moderate to severe chronic pain in opioid-tolerant patients when a continuous, around-the-clock opioid analgesic is needed for an extended period of time.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA MedWatch program, using the contact information at the bottom of this page.

Safety Information

Regulatory History and Labeling from Drugs@FDA

More Information

Back to Top